SCHEMBL1446837

SCHEMBL1446837

CCC1=C2C(=O)OCC12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8633447 0.70
SCHEMBL3092802 0.59
SCHEMBL28941053 0.58 MAOA (0.38)
SCHEMBL2375717 0.56
SCHEMBL5104504 0.55
SCHEMBL16404036 0.55
SCHEMBL6702328 0.54
SCHEMBL6426044 0.54
SCHEMBL19346208 0.53
SCHEMBL14748808 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0224349-A1 Chemically modified polyolefin NESTE OY (FI) 1987-06-03 EP claimed
US-20110112116-A1 COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS SINGH NIKHILESH N 2011-05-12 US disclosed
EP-2301493-A1 Sustained analgesia achieved with buprenorphine EURO-CELTIQUE S.A. (LU) 2011-03-30 EP disclosed
EP-1458559-B1 LABEL FILMS AND LABELING PROCESS AVERY DENNISON CORP (US) 2010-02-17 EP disclosed